title: Preparation, characterization and pharmacokinetic studies of linalool-loaded nanostructured lipid carriers.
abstract: Context Linalool (LL) is associated with numerous pharmacological activities. However, its poor solubility usually results in poor bioavailability, and further limited its applications. Objective To reduce volatilization and improve bioavailability of LL, linalool-loaded nanostructured lipid carriers (LL-NLCs) were prepared. Materials and methods LL-NLCs were prepared using high-pressure homogenization method and optimized via response surface methodology-central composite design, followed by characterization, including particle size (PS), zeta potential (ZP), transmission electron microscope (TEM), X-ray diffraction (XRD), differential scanning calorimetry (DSC) and in vitro release study. Rats were administered 300 mg × kg (-) (1) LL with each preparation (LL-NLCs or LL) via oral gavage. Results LL-NLCs had a PS of 52.72 nm with polydispersity index of 0.172, and ZP of -16.0 mV. The encapsulation efficiency and drug loading gave 79.563 and 7.555%, respectively. The cumulative release of LL from free LL reached 51.414% at 180 min, while LL from LL-NLCs was 15.564%. All the pharmacokinetics parameters of LL-NLCs were better than those of LL, including Cmax (from 1915.45 to 2182.45 ng × mL (-) (1)), AUC0-t (from 76003.40 to 298948.46 ng × min × mL (-) (1)) and relative bioavailability (393.34%). The t1/2, MRT and tmax of LL-NLCs (110.50, 146.66 and 60 min) were also longer than that of LL (44.72, 45.66 and 40 min). Discussion and conclusion LL-NLCs were for the first time prepared and its oral administration in rats thoroughly investigated. LL-NLCs exhibited sustained release effect and increased absorption of LL. Therefore, these findings might provide a potential possibility for clinical application of LL.
authors.affiliation: a Department of Pharmaceutics , School of Pharmacy Center for Nano Drug/Gene Delivery and Tissue Engineering, Jiangsu University , Zhenjiang , PR China.
authors.forename: Feng
authors.initials: F
authors.lastname: Shi
authors.affiliation: a Department of Pharmaceutics , School of Pharmacy Center for Nano Drug/Gene Delivery and Tissue Engineering, Jiangsu University , Zhenjiang , PR China.
authors.forename: Yingying
authors.initials: Y
authors.lastname: Zhao
authors.affiliation: a Department of Pharmaceutics , School of Pharmacy Center for Nano Drug/Gene Delivery and Tissue Engineering, Jiangsu University , Zhenjiang , PR China.
authors.forename: Caleb Kesse
authors.initials: CK
authors.lastname: Firempong
authors.affiliation: a Department of Pharmaceutics , School of Pharmacy Center for Nano Drug/Gene Delivery and Tissue Engineering, Jiangsu University , Zhenjiang , PR China.
authors.forename: Ximing
authors.initials: X
authors.lastname: Xu
mesh_terms: D000080462:Acyclic Monoterpenes; D000284:Administration, Oral; D000818:Animals; D019540:Area Under Curve; D001682:Biological Availability; D003692:Delayed-Action Preparations; D004337:Drug Carriers; D004339:Drug Compounding; D007441:Intubation, Gastrointestinal; D008055:Lipids / Q000737:chemistry*; D008297:Male; D008954:Models, Biological; D039821:Monoterpenes / Q000008:administration & dosage / Q000097:blood / Q000737:chemistry / Q000493:pharmacokinetics*; D053758:Nanoparticles; D010936:Plant Extracts / Q000008:administration & dosage / Q000097:blood / Q000737:chemistry / Q000493:pharmacokinetics*; D017207:Rats, Sprague-Dawley; D012995:Solubility
chemical_list: D000080462:Acyclic Monoterpenes; D003692:Delayed-Action Preparations; D004337:Drug Carriers; D008055:Lipids; D039821:Monoterpenes; D010936:Plant Extracts; C018584:linalool
keywords: Essential oil; high-pressure homogenization; response surface methodology